Australias CSL reports half-year profit jump on strong demand for immunoglobulin products
Australias biotech giant CSL Ltd reported a 5% rise in its first-half profit on Tuesday, boosted by growth in its…
137,480€
0,11%
Echtzeit-Aktienkurs CSL Ltd.
Bid:
Ask: